Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A predictive model for aggressive non-Hodgkin's lymphoma

Margaret A. Shipp, David P. Harrington, J R Anderson et al. · 1993 · 3.5K citations

Medicine, Oncology, Chemotherapy +15

International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

Journal of Clinical Oncology · 2008 · 2.1K citations

Medicine, Hematology, Pathology +14

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

Barbara Pro, Ranjana H. Advani, Pauline Brice et al. · Journal of Clinical Oncology · 2012 · 990 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

Kerry J. Savage, Nancy L. Harris, Julie M. Vose et al. · Blood · 2008 · 854 citations · Full text

Medicine, Oncology, Pathology +12

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

Owen A. O’Connor, Barbara Pro, Lauren Pinter‐Brown et al. · Journal of Clinical Oncology · 2011 · 643 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15